This educational and promotional event is organised and funded by Flynn Pharma Ltd.
The perils of poor sleep: treatment approaches in children with autism and intellectual disabilities
Agenda
Ashley is Consultant Paediatric Neuropsychiatrist in the tertiary paediatric neurodevelopmental service at the Evelina London Children’s Hospital, and in the paediatric liaison mental health service (National and Specialist CAMHS) at South London and Maudsley NHS Foundation Trust. His clinical expertise and academic interests are in neurodevelopmental conditions (intellectual disabilities, autism, ADHD, tics), mental health conditions co-occurring with neurological conditions (epilepsy, neuroinflammatory conditions, brain injury), and complex psychopharmacology (in children with neurological and cardiac conditions).
Ashley trained previously in Paediatrics and has postgraduate qualifications in Clinical Neuropsychiatry and Digital Health Leadership. He is an Honorary Associate Professor at the University of Warwick, and Honorary Senior Research Fellow at the University of Birmingham. Ashley is Joint Chair of the Scientific Advisory Committee of the Smith-Magenis Syndrome Foundation, and has held leadership and advisory positions at the Royal College of Psychiatrists, NICE, Health Education England, and NHS England.
What will the webinar cover?
Key learning objectives
- To look at a range of approaches for the effective management of sleep difficulties in young people with neurodevelopmental disorders.
